European Companies Search Engine
MD (3) · ppa (1) · Profit Transfer: Boehringer Ingelheim Vetmedica GmbH · Change of headquarters: Bioscreen European Veterinary Disease Management Center GmbH · Address · Capital: €125,270 … Hrb 7 Feb 2012 German Trade Register Announcements, Germany (31/01/2012)
Overview
Text
Bioscreen European Veterinary Disease Management Center GmbH,
Unnamed street ??, 30559 Hannover, Germany
. GmbH. Partnership agreement of November 26, 1997, amended several times. The Shareholders' Meeting of December 5, 2011 approved the amendment of the partnership agreement in Section 1 (Company, the transfer of its registered office from Münster (previously Amtsgericht Münster HRB 5106) to Hanover, as well as the amendment in Section 3 (share capital) and with it the conversion of the share capital from DM 245,000.00 to EUR 125,266.51 and the increase of EUR 3.49 to EUR 125,270.00 and the complete recasting of the company agreement. Business address:
Unnamed street ??, 30559 Hannover, Germany
. The purpose is to set up a service centre for laboratory diagnosis of infectious and rearing diseases in animals, in particular pigs, to develop diagnostic test systems and procedures, to research in the field of pathogenesis, epidemiology, prophylaxis and disease treatment, and to advise and train veterinarians. Share capital: EUR 125,270.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Director: Dr. ??????????, ???????, Mainz, *??.??.????; Dr. Ohlinger, Volker, Münster, *??.??.????; ????, ??????, Bingen, *??.??.????. Gesamtprokura together with a managing director or another authorized representative: ?????, ???????, Essenheim, *??.??.????. On June 4, 1998, a profit transfer agreement was concluded with Beohringer Ingelheim Vetmedica GmbH (Amtsgericht Mainz HRB 21491) a.s. the dominant company with confirmation of June 5, 1998. It was approved by the Shareholders' Meeting of June 16, 1998. In view of the further content, reference is made to the said treaty and to the decisions approving it.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Boehringer Ingelheim Animal Health Participations GmbH, Ingelheim a. Rhein, Germany.